<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-5FFC4HAU</identifier><date>2004</date><creator>Stocco, Gabriele</creator><relation>documents/znanstveni_clanki/radiology_and_oncology/html/urn_nbn_si_doc-5ffc4hau.html</relation><relation>documents/znanstveni_clanki/radiology_and_oncology/pdf/urn_nbn_si_doc-5ffc4hau.pdf</relation><relation>documents/znanstveni_clanki/radiology_and_oncology/txt/urn_nbn_si_doc-5ffc4hau.txt</relation><format format_type="issue">2</format><format format_type="volume">38</format><format format_type="main">9 strani</format><format format_type="type">article</format><format format_type="extent">str. 101-109</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">18166489</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-5FFC4HAU</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">6-Mercaptopurine</subject><subject language_type_id="slv">6-merkaptopurin</subject><subject language_type_id="eng">Azathioprine</subject><subject language_type_id="slv">Azatioprin</subject><subject language_type_id="eng">Chromatography, High Pressure Liquid</subject><subject language_type_id="slv">črevesne bolezni</subject><subject language_type_id="eng">diagnostika</subject><subject language_type_id="eng">Drug Therapy</subject><subject language_type_id="eng">Genetics</subject><subject language_type_id="slv">Genotip</subject><subject language_type_id="eng">Genotype</subject><subject language_type_id="eng">Inflammatory Bowel Diseases</subject><subject language_type_id="slv">Kromatografija visokotlačna, tekočinska</subject><subject language_type_id="eng">Methyltransferases</subject><subject language_type_id="slv">Metiltransferaze</subject><subject language_type_id="slv">mutacije</subject><subject language_type_id="slv">Polimerazna, verižna reakcija</subject><subject language_type_id="slv">Polimorfizem, omejene dolžine fragmentov</subject><subject language_type_id="eng">Polymerase Chain Reaction</subject><subject language_type_id="eng">Polymorphism, Restriction Fragment Length</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">Vnetne, črevesne bolezni</subject><subject language_type_id="slv">zdravljenje</subject><title>can posology be guided by laboratory data?</title><title>Pharmacogenetics of thiopurines</title></Record>